Company / Book Value per Share
Ovid Therapeutics Inc. Book Value per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.961
FY2025
5-year range
$0.961 / $2.554
FY2022-FY2025
Trend
-22.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has declined for 3 consecutive years, from $2.554 in FY2022 to $0.961 in FY2025.
Based on SEC 10-K filings.
$0.961 in FY2025 with a 3-year CAGR of -27.8%.
Declined from $1.877 to $0.961 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -27.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Ovid Therapeutics Inc.'s book value per share has declined for 3 consecutive years.
- 3-year CAGR of -27.8%, indicating a declining trend.
- In FY2025, book value per share decreased 22.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.961 | -22.6% |
| FY2024 | $1.242 | -33.8% |
| FY2023 | $1.877 | -26.5% |
| FY2022 | $2.554 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026